Evotec and Rappta Therapeutics enter discovery and development partnership focused on oncology target

Evotec SE today announced a new multi-year drug development partnership with Rappta Therapeutics, a Finland-based biopharmaceutical company, focused on an innovative oncology target. 
Read More